about
Influence of non-enzymatic post-translation modifications on the ability of human serum albumin to bind iron. Implications for non-transferrin-bound iron speciationHypoxia enhances the malignant nature of bladder cancer cells and concomitantly antagonizes protein O-glycosylation extension.Monitoring the efficiency of iron chelation therapy: the potential of nontransferrin-bound iron.In silico approaches for unveiling novel glycobiomarkers in cancer.Street-Like Synthesis of Krokodil Results in the Formation of an Enlarged Cluster of Known and New Morphinans.Targeted O-glycoproteomics explored increased sialylation and identified MUC16 as a poor prognosis biomarker in advanced-stage bladder tumours.The glycation site specificity of human serum transferrin is a determinant for transferrin's functional impairment under elevated glycaemic conditions.Iron(III) citrate speciation in aqueous solution.Distinctive EPR signals provide an understanding of the affinity of bis-(3-hydroxy-4-pyridinonato) copper(II) complexes for hydrophobic environments.Identification of distinct nanoparticles and subsets of extracellular vesicles by asymmetric flow field-flow fractionation.Iron(III) Fluorinated Porphyrins: Greener Chemistry from Synthesis to Oxidative Catalysis Reactions.Chlorogenic acid-arabinose hybrid domains in coffee melanoidins: Evidences from a model system.The efficiency of trypsin digestion for mass-spectrometry-based identification and quantification of oxidized proteins: evaluation of the digestion of oxidized bovine serum albumin.Tuning the Anti(myco)bacterial Activity of 3-Hydroxy-4-pyridinone Chelators through FluorophoresDetermining the glycation site specificity of human holo-transferrinNucleolin-Sle A Glycoforms as E-Selectin Ligands and Potentially Targetable Biomarkers at the Cell Surface of Gastric Cancer CellsAtherosclerosis is aggravated by iron overload and ameliorated by dietary and pharmacological iron restriction
P50
Q28247753-29E271AC-0669-46A4-89D1-1803AB46F750Q37665276-915F1979-7238-44C2-BC3F-7F3123791375Q37780291-BEC162D7-97DF-4D43-BDDF-BB5CB8519F56Q38637419-9086D547-B873-4479-8D56-B12471D5B011Q38678785-739A71F5-3404-430A-9EA6-DEF56B4ABAC1Q41194359-F76DC537-3282-4EF6-AFAB-80B55A02DD40Q42653614-59CC9758-3438-4052-8278-E4CC6B5316DDQ43265936-DD1B17DD-AEEA-42E7-BA5B-18B123DEB26AQ46893586-3687354E-2456-4ACF-ACE5-5E953271408BQ49829985-6458FA26-701F-488E-AE46-B9F80BCC7B77Q50229812-9AD96448-B9F7-435A-BF6F-0629143C77E4Q50277980-82632EE3-563C-4A01-B838-158045FC29CCQ51081772-67E668A9-5CBE-4A84-8BAD-7C5550DA0457Q57808855-97DBC893-F6E9-4CC3-B404-552167F34A6CQ57990863-36DB8E98-74CC-4BEA-A81C-1654EFBA9311Q91603082-9716ABA3-D4F7-460B-A904-71A453346DB0Q92565338-5DB8D0CE-24C0-40C3-AE35-7D171119B092
P50
description
Forscher
@de
chercheur
@fr
investigador
@es
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
研究者
@zh
name
André M.N. Silva
@ast
André M.N. Silva
@en
André M.N. Silva
@es
André M.N. Silva
@nl
type
label
André M.N. Silva
@ast
André M.N. Silva
@en
André M.N. Silva
@es
André M.N. Silva
@nl
prefLabel
André M.N. Silva
@ast
André M.N. Silva
@en
André M.N. Silva
@es
André M.N. Silva
@nl
P1153
26653803700
P31
P496
0000-0001-5554-7714